Guidance for Industry: Proper Labeling of Honey and Honey Products


How to Comment

You may submit electronic or written comments regarding this guidance at any time starting on March 2, 2018.

Submit electronic comments to to docket number FDA-2006-P-0207.

Submit written comments to:

Dockets Management Staff (HFA-305)
Food and Drug Administration
5630 Fishers Lane, rm. 1061
Rockville, MD 20852
All comments should be identified with the docket number FDA-2006-P-0207. 

Contains Nonbinding Recommendations

February 2018

This guidance is intended to advise the regulated industry on the proper labeling of honey and honey products in accordance with sections 402 and 403 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 342 and 343) and its implementing regulations.

Accurate and consistent labeling of honey and honey products helps to ensure that honey and honey products are not adulterated or misbranded and enhances consumers’ ability to make informed choices among products.

FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities.

Instead, guidances describe our current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in FDA guidances means that something is suggested or recommended, but not required.

Throughout this guidance, “you” refers to firms that manufacture, process, pack, label, or distribute honey and honey products and to persons who are authorized to act on behalf of such firms.  

Download the Guidance for Industry

Page Last Updated: 09/16/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English